Poking CD40 for cancer therapy, another example of the Goldilocks effect.
Milton S Hershey Medical Center, Hershey, PA USA. jdrabick@psu.hmc.edu
Joseph J
JJ
Drabick
Todd D
TD
Schell
D000911:Antibodies, Monoclonal / Q000493:pharmacokinetics / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D019013:CD40 Antigens / Q000819:agonists*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology*; D012074:Remission Induction
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D019013:CD40 Antigens; C518149:selicrelumab